Page last updated: 2024-10-22

beta-aminoethyl isothiourea and Methemoglobinemia

beta-aminoethyl isothiourea has been researched along with Methemoglobinemia in 1 studies

beta-Aminoethyl Isothiourea: A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goepp, RA1
Fitch, FW1
Doull, J1

Other Studies

1 other study available for beta-aminoethyl isothiourea and Methemoglobinemia

ArticleYear
The use of parenteral chemicals for protection against oral radiation death in mice.
    Radiation research, 1967, Volume: 31, Issue:1

    Topics: Animals; beta-Aminoethyl Isothiourea; Head; Hyperbaric Oxygenation; Injections, Intraperitoneal; Mal

1967